Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Erlangen
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
2016
|
| Schlagworte: | |
| Online-Zugang: | Volltext Volltext Volltext |
| Beschreibung: | Aus: Annals of Oncology 26.12 (2015): S. 2392-2398. <http://annonc.oxfordjournals.org/content/26/12/2392.abstract> Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich. This publication is with permission of the rights owner freely accessible due to an Alliance licence or a national licence (funded by the DFG, German Research Foundation) respectively. |
| Beschreibung: | 1 Online-Ressource |
| Format: | Langzeitarchivierung gewährleistet, LZA |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043797453 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 160927s2016 gw |||| o||u| ||||||eng d | ||
| 015 | |a 16,O10 |2 dnb | ||
| 016 | 7 | |a 1113291559 |2 DE-101 | |
| 024 | 7 | |a urn:nbn:de:bvb:29-opus4-75268 |2 urn | |
| 035 | |a (OCoLC)959665726 | ||
| 035 | |a (DE-599)DNB1113291559 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 044 | |a gw |c XA-DE-BY | ||
| 049 | |a DE-29 | ||
| 082 | 0 | |a 610 |2 23 | |
| 084 | |a 610 |2 sdnb | ||
| 100 | 1 | |a Kramar, A. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials |b results of the DATECAN project |c A. Kramar ; S. Negrier ; R. Sylvester ; S. Joniau ; P. Mulders ; T. Powles ; A. Bex ; F. Bonnetain ; A. Bossi ; S. Bracarda ; R. Bukowski ; J. Catto ; T. K. Choueiri ; S. Crabb ; T. Eisen ; M. El Demery ; J. Fitzpatrick ; V. Flamand ; P. J. Goebell ; G. Gravis ; N. Houédé ; D. Jacqmin ; R. Kaplan ; B. Malavaud ; C. Massard ; B. Melichar ; L. Mourey ; P. Nathan ; D. Pasquier ; C. Porta ; D. Pouessel ; D. Quinn ; A. Ravaud ; F. Rolland ; M. Schmidinger ; B. Tombal ; D. Tosi ; E. Vauleon ; A. Volpe ; P. Wolter ; B. Escudier ; T. Filleron |
| 264 | 1 | |a Erlangen |b Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) |c 2016 | |
| 300 | |a 1 Online-Ressource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Aus: Annals of Oncology 26.12 (2015): S. 2392-2398. <http://annonc.oxfordjournals.org/content/26/12/2392.abstract> | ||
| 500 | |a Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich. | ||
| 500 | |a This publication is with permission of the rights owner freely accessible due to an Alliance licence or a national licence (funded by the DFG, German Research Foundation) respectively. | ||
| 538 | |a Langzeitarchivierung gewährleistet, LZA | ||
| 653 | |a clinical trials | ||
| 653 | |a DATECAN | ||
| 653 | |a recommendations | ||
| 653 | |a renal cell cancer | ||
| 653 | |a time-to-event end points | ||
| 700 | 1 | |a Negrier, S. |e Verfasser |4 aut | |
| 700 | 1 | |a Sylvester, R. |e Verfasser |4 aut | |
| 700 | 1 | |a Joniau, S. |e Verfasser |4 aut | |
| 700 | 1 | |a Mulders, P. |e Verfasser |4 aut | |
| 700 | 1 | |a Powles, T. |e Verfasser |4 aut | |
| 700 | 1 | |a Bex, A. |e Verfasser |4 aut | |
| 700 | 1 | |a Bonnetain, F. |e Verfasser |4 aut | |
| 700 | 1 | |a Bossi, A. |e Verfasser |4 aut | |
| 700 | 1 | |a Bracarda, S. |e Verfasser |4 aut | |
| 700 | 1 | |a Bukowski, R. |e Verfasser |4 aut | |
| 700 | 1 | |a Catto, J. |e Verfasser |4 aut | |
| 700 | 1 | |a Choueiri, T. K. |e Verfasser |4 aut | |
| 700 | 1 | |a Crabb, S. |e Verfasser |4 aut | |
| 700 | 1 | |a Eisen, T. |e Verfasser |4 aut | |
| 700 | 1 | |a El Demery, M. |e Verfasser |4 aut | |
| 700 | 1 | |a Fitzpatrick, J. |e Verfasser |0 (DE-588)103755195 |4 aut | |
| 700 | 1 | |a Flamand, V. |e Verfasser |4 aut | |
| 700 | 1 | |a Goebell, P. J. |e Verfasser |4 aut | |
| 700 | 1 | |a Gravis, G. |e Verfasser |4 aut | |
| 700 | 1 | |a Houédé, N. |e Verfasser |4 aut | |
| 700 | 1 | |a Jacqmin, D. |e Verfasser |4 aut | |
| 700 | 1 | |a Kaplan, R. |e Verfasser |4 aut | |
| 700 | 1 | |a Malavaud, B. |e Verfasser |4 aut | |
| 700 | 1 | |a Massard, C. |e Verfasser |4 aut | |
| 856 | 4 | 0 | |u https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-75268 |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://d-nb.info/1113291559/34 |x Langzeitarchivierung Nationalbibliothek |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://open.fau.de/handle/openfau/7526 |x Verlag |z kostenfrei |3 Volltext |
| 912 | |a ebook | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029208883 | ||
Datensatz im Suchindex
| _version_ | 1804176642237530112 |
|---|---|
| any_adam_object | |
| author | Kramar, A. Negrier, S. Sylvester, R. Joniau, S. Mulders, P. Powles, T. Bex, A. Bonnetain, F. Bossi, A. Bracarda, S. Bukowski, R. Catto, J. Choueiri, T. K. Crabb, S. Eisen, T. El Demery, M. Fitzpatrick, J. Flamand, V. Goebell, P. J. Gravis, G. Houédé, N. Jacqmin, D. Kaplan, R. Malavaud, B. Massard, C. |
| author_GND | (DE-588)103755195 |
| author_facet | Kramar, A. Negrier, S. Sylvester, R. Joniau, S. Mulders, P. Powles, T. Bex, A. Bonnetain, F. Bossi, A. Bracarda, S. Bukowski, R. Catto, J. Choueiri, T. K. Crabb, S. Eisen, T. El Demery, M. Fitzpatrick, J. Flamand, V. Goebell, P. J. Gravis, G. Houédé, N. Jacqmin, D. Kaplan, R. Malavaud, B. Massard, C. |
| author_role | aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut |
| author_sort | Kramar, A. |
| author_variant | a k ak s n sn r s rs s j sj p m pm t p tp a b ab f b fb a b ab s b sb r b rb j c jc t k c tk tkc s c sc t e te d m e dm dme j f jf v f vf p j g pj pjg g g gg n h nh d j dj r k rk b m bm c m cm |
| building | Verbundindex |
| bvnumber | BV043797453 |
| collection | ebook |
| ctrlnum | (OCoLC)959665726 (DE-599)DNB1113291559 |
| dewey-full | 610 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 610 - Medicine and health |
| dewey-raw | 610 |
| dewey-search | 610 |
| dewey-sort | 3610 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03628nmm a2200757zc 4500</leader><controlfield tag="001">BV043797453</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">160927s2016 gw |||| o||u| ||||||eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">16,O10</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1113291559</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">urn:nbn:de:bvb:29-opus4-75268</subfield><subfield code="2">urn</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)959665726</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1113291559</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BY</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Kramar, A.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials</subfield><subfield code="b">results of the DATECAN project</subfield><subfield code="c">A. Kramar ; S. Negrier ; R. Sylvester ; S. Joniau ; P. Mulders ; T. Powles ; A. Bex ; F. Bonnetain ; A. Bossi ; S. Bracarda ; R. Bukowski ; J. Catto ; T. K. Choueiri ; S. Crabb ; T. Eisen ; M. El Demery ; J. Fitzpatrick ; V. Flamand ; P. J. Goebell ; G. Gravis ; N. Houédé ; D. Jacqmin ; R. Kaplan ; B. Malavaud ; C. Massard ; B. Melichar ; L. Mourey ; P. Nathan ; D. Pasquier ; C. Porta ; D. Pouessel ; D. Quinn ; A. Ravaud ; F. Rolland ; M. Schmidinger ; B. Tombal ; D. Tosi ; E. Vauleon ; A. Volpe ; P. Wolter ; B. Escudier ; T. Filleron</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Erlangen</subfield><subfield code="b">Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)</subfield><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Aus: Annals of Oncology 26.12 (2015): S. 2392-2398. <http://annonc.oxfordjournals.org/content/26/12/2392.abstract></subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich.</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">This publication is with permission of the rights owner freely accessible due to an Alliance licence or a national licence (funded by the DFG, German Research Foundation) respectively.</subfield></datafield><datafield tag="538" ind1=" " ind2=" "><subfield code="a">Langzeitarchivierung gewährleistet, LZA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">clinical trials</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">DATECAN</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">recommendations</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">renal cell cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">time-to-event end points</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Negrier, S.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sylvester, R.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Joniau, S.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mulders, P.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Powles, T.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bex, A.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bonnetain, F.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bossi, A.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bracarda, S.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bukowski, R.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Catto, J.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Choueiri, T. K.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Crabb, S.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Eisen, T.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">El Demery, M.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fitzpatrick, J.</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)103755195</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Flamand, V.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Goebell, P. J.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gravis, G.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Houédé, N.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jacqmin, D.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kaplan, R.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Malavaud, B.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Massard, C.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-75268</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://d-nb.info/1113291559/34</subfield><subfield code="x">Langzeitarchivierung Nationalbibliothek</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://open.fau.de/handle/openfau/7526</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029208883</subfield></datafield></record></collection> |
| id | DE-604.BV043797453 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:35:25Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029208883 |
| oclc_num | 959665726 |
| open_access_boolean | 1 |
| owner | DE-29 |
| owner_facet | DE-29 |
| physical | 1 Online-Ressource |
| psigel | ebook |
| publishDate | 2016 |
| publishDateSearch | 2016 |
| publishDateSort | 2016 |
| publisher | Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) |
| record_format | marc |
| spelling | Kramar, A. Verfasser aut Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials results of the DATECAN project A. Kramar ; S. Negrier ; R. Sylvester ; S. Joniau ; P. Mulders ; T. Powles ; A. Bex ; F. Bonnetain ; A. Bossi ; S. Bracarda ; R. Bukowski ; J. Catto ; T. K. Choueiri ; S. Crabb ; T. Eisen ; M. El Demery ; J. Fitzpatrick ; V. Flamand ; P. J. Goebell ; G. Gravis ; N. Houédé ; D. Jacqmin ; R. Kaplan ; B. Malavaud ; C. Massard ; B. Melichar ; L. Mourey ; P. Nathan ; D. Pasquier ; C. Porta ; D. Pouessel ; D. Quinn ; A. Ravaud ; F. Rolland ; M. Schmidinger ; B. Tombal ; D. Tosi ; E. Vauleon ; A. Volpe ; P. Wolter ; B. Escudier ; T. Filleron Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) 2016 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Aus: Annals of Oncology 26.12 (2015): S. 2392-2398. <http://annonc.oxfordjournals.org/content/26/12/2392.abstract> Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich. This publication is with permission of the rights owner freely accessible due to an Alliance licence or a national licence (funded by the DFG, German Research Foundation) respectively. Langzeitarchivierung gewährleistet, LZA clinical trials DATECAN recommendations renal cell cancer time-to-event end points Negrier, S. Verfasser aut Sylvester, R. Verfasser aut Joniau, S. Verfasser aut Mulders, P. Verfasser aut Powles, T. Verfasser aut Bex, A. Verfasser aut Bonnetain, F. Verfasser aut Bossi, A. Verfasser aut Bracarda, S. Verfasser aut Bukowski, R. Verfasser aut Catto, J. Verfasser aut Choueiri, T. K. Verfasser aut Crabb, S. Verfasser aut Eisen, T. Verfasser aut El Demery, M. Verfasser aut Fitzpatrick, J. Verfasser (DE-588)103755195 aut Flamand, V. Verfasser aut Goebell, P. J. Verfasser aut Gravis, G. Verfasser aut Houédé, N. Verfasser aut Jacqmin, D. Verfasser aut Kaplan, R. Verfasser aut Malavaud, B. Verfasser aut Massard, C. Verfasser aut https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-75268 Resolving-System kostenfrei Volltext http://d-nb.info/1113291559/34 Langzeitarchivierung Nationalbibliothek kostenfrei Volltext https://open.fau.de/handle/openfau/7526 Verlag kostenfrei Volltext |
| spellingShingle | Kramar, A. Negrier, S. Sylvester, R. Joniau, S. Mulders, P. Powles, T. Bex, A. Bonnetain, F. Bossi, A. Bracarda, S. Bukowski, R. Catto, J. Choueiri, T. K. Crabb, S. Eisen, T. El Demery, M. Fitzpatrick, J. Flamand, V. Goebell, P. J. Gravis, G. Houédé, N. Jacqmin, D. Kaplan, R. Malavaud, B. Massard, C. Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials results of the DATECAN project |
| title | Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials results of the DATECAN project |
| title_auth | Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials results of the DATECAN project |
| title_exact_search | Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials results of the DATECAN project |
| title_full | Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials results of the DATECAN project A. Kramar ; S. Negrier ; R. Sylvester ; S. Joniau ; P. Mulders ; T. Powles ; A. Bex ; F. Bonnetain ; A. Bossi ; S. Bracarda ; R. Bukowski ; J. Catto ; T. K. Choueiri ; S. Crabb ; T. Eisen ; M. El Demery ; J. Fitzpatrick ; V. Flamand ; P. J. Goebell ; G. Gravis ; N. Houédé ; D. Jacqmin ; R. Kaplan ; B. Malavaud ; C. Massard ; B. Melichar ; L. Mourey ; P. Nathan ; D. Pasquier ; C. Porta ; D. Pouessel ; D. Quinn ; A. Ravaud ; F. Rolland ; M. Schmidinger ; B. Tombal ; D. Tosi ; E. Vauleon ; A. Volpe ; P. Wolter ; B. Escudier ; T. Filleron |
| title_fullStr | Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials results of the DATECAN project A. Kramar ; S. Negrier ; R. Sylvester ; S. Joniau ; P. Mulders ; T. Powles ; A. Bex ; F. Bonnetain ; A. Bossi ; S. Bracarda ; R. Bukowski ; J. Catto ; T. K. Choueiri ; S. Crabb ; T. Eisen ; M. El Demery ; J. Fitzpatrick ; V. Flamand ; P. J. Goebell ; G. Gravis ; N. Houédé ; D. Jacqmin ; R. Kaplan ; B. Malavaud ; C. Massard ; B. Melichar ; L. Mourey ; P. Nathan ; D. Pasquier ; C. Porta ; D. Pouessel ; D. Quinn ; A. Ravaud ; F. Rolland ; M. Schmidinger ; B. Tombal ; D. Tosi ; E. Vauleon ; A. Volpe ; P. Wolter ; B. Escudier ; T. Filleron |
| title_full_unstemmed | Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials results of the DATECAN project A. Kramar ; S. Negrier ; R. Sylvester ; S. Joniau ; P. Mulders ; T. Powles ; A. Bex ; F. Bonnetain ; A. Bossi ; S. Bracarda ; R. Bukowski ; J. Catto ; T. K. Choueiri ; S. Crabb ; T. Eisen ; M. El Demery ; J. Fitzpatrick ; V. Flamand ; P. J. Goebell ; G. Gravis ; N. Houédé ; D. Jacqmin ; R. Kaplan ; B. Malavaud ; C. Massard ; B. Melichar ; L. Mourey ; P. Nathan ; D. Pasquier ; C. Porta ; D. Pouessel ; D. Quinn ; A. Ravaud ; F. Rolland ; M. Schmidinger ; B. Tombal ; D. Tosi ; E. Vauleon ; A. Volpe ; P. Wolter ; B. Escudier ; T. Filleron |
| title_short | Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials |
| title_sort | guidelines for the definition of time to event end points in renal cell cancer clinical trials results of the datecan project |
| title_sub | results of the DATECAN project |
| url | https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-75268 http://d-nb.info/1113291559/34 https://open.fau.de/handle/openfau/7526 |
| work_keys_str_mv | AT kramara guidelinesforthedefinitionoftimetoeventendpointsinrenalcellcancerclinicaltrialsresultsofthedatecanproject AT negriers guidelinesforthedefinitionoftimetoeventendpointsinrenalcellcancerclinicaltrialsresultsofthedatecanproject AT sylvesterr guidelinesforthedefinitionoftimetoeventendpointsinrenalcellcancerclinicaltrialsresultsofthedatecanproject AT joniaus guidelinesforthedefinitionoftimetoeventendpointsinrenalcellcancerclinicaltrialsresultsofthedatecanproject AT muldersp guidelinesforthedefinitionoftimetoeventendpointsinrenalcellcancerclinicaltrialsresultsofthedatecanproject AT powlest guidelinesforthedefinitionoftimetoeventendpointsinrenalcellcancerclinicaltrialsresultsofthedatecanproject AT bexa guidelinesforthedefinitionoftimetoeventendpointsinrenalcellcancerclinicaltrialsresultsofthedatecanproject AT bonnetainf guidelinesforthedefinitionoftimetoeventendpointsinrenalcellcancerclinicaltrialsresultsofthedatecanproject AT bossia guidelinesforthedefinitionoftimetoeventendpointsinrenalcellcancerclinicaltrialsresultsofthedatecanproject AT bracardas guidelinesforthedefinitionoftimetoeventendpointsinrenalcellcancerclinicaltrialsresultsofthedatecanproject AT bukowskir guidelinesforthedefinitionoftimetoeventendpointsinrenalcellcancerclinicaltrialsresultsofthedatecanproject AT cattoj guidelinesforthedefinitionoftimetoeventendpointsinrenalcellcancerclinicaltrialsresultsofthedatecanproject AT choueiritk guidelinesforthedefinitionoftimetoeventendpointsinrenalcellcancerclinicaltrialsresultsofthedatecanproject AT crabbs guidelinesforthedefinitionoftimetoeventendpointsinrenalcellcancerclinicaltrialsresultsofthedatecanproject AT eisent guidelinesforthedefinitionoftimetoeventendpointsinrenalcellcancerclinicaltrialsresultsofthedatecanproject AT eldemerym guidelinesforthedefinitionoftimetoeventendpointsinrenalcellcancerclinicaltrialsresultsofthedatecanproject AT fitzpatrickj guidelinesforthedefinitionoftimetoeventendpointsinrenalcellcancerclinicaltrialsresultsofthedatecanproject AT flamandv guidelinesforthedefinitionoftimetoeventendpointsinrenalcellcancerclinicaltrialsresultsofthedatecanproject AT goebellpj guidelinesforthedefinitionoftimetoeventendpointsinrenalcellcancerclinicaltrialsresultsofthedatecanproject AT gravisg guidelinesforthedefinitionoftimetoeventendpointsinrenalcellcancerclinicaltrialsresultsofthedatecanproject AT houeden guidelinesforthedefinitionoftimetoeventendpointsinrenalcellcancerclinicaltrialsresultsofthedatecanproject AT jacqmind guidelinesforthedefinitionoftimetoeventendpointsinrenalcellcancerclinicaltrialsresultsofthedatecanproject AT kaplanr guidelinesforthedefinitionoftimetoeventendpointsinrenalcellcancerclinicaltrialsresultsofthedatecanproject AT malavaudb guidelinesforthedefinitionoftimetoeventendpointsinrenalcellcancerclinicaltrialsresultsofthedatecanproject AT massardc guidelinesforthedefinitionoftimetoeventendpointsinrenalcellcancerclinicaltrialsresultsofthedatecanproject |